These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9472514)

  • 21. Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction.
    Huber K; De Caterina R; Kristensen SD; Verheugt FW; Montalescot G; Maestro LB; Van de Werf F;
    Eur Heart J; 2005 Oct; 26(19):2063-74. PubMed ID: 16055497
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment strategies after successful thrombolysis in acute myocardial infarction.
    Ramsden CS
    Heart Lung; 1988 Nov; 17(6 Pt 2):777-82. PubMed ID: 2973449
    [No Abstract]   [Full Text] [Related]  

  • 23. Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy.
    White CW
    Circulation; 1989 Nov; 80(5):1482-5. PubMed ID: 2805279
    [No Abstract]   [Full Text] [Related]  

  • 24. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 25. Progress in interventional cardiology.
    Talley JD
    J Interv Cardiol; 1993 Mar; 6(1):89-94. PubMed ID: 10150990
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction.
    Arjomand H; Sokil AB; Arjmand R; Fischer HA; Wolf NM
    J Invasive Cardiol; 2001 Sep; 13(9):647-50. PubMed ID: 11533504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing times in the treatment of myocardial infarction.
    Leitch JW
    Med J Aust; 2003 Apr; 178(8):367-8. PubMed ID: 12697006
    [No Abstract]   [Full Text] [Related]  

  • 28. Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach.
    Gulba DC
    Thromb Haemost; 1999 Aug; 82(2):953-61. PubMed ID: 10605809
    [No Abstract]   [Full Text] [Related]  

  • 29. Thrombolytic therapy for acute myocardial infarction--yesterday, today, tomorrow.
    Djurdjev A
    Folia Med (Plovdiv); 1995; 37(4A Suppl):43-4. PubMed ID: 8655053
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction.
    Antman EM; Van de Werf F
    Circulation; 2004 Jun; 109(21):2480-6. PubMed ID: 15173037
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute myocardial infarction.
    Talley JD
    J Interv Cardiol; 1994 Apr; 7(2):205-7. PubMed ID: 10151047
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvants to thrombolysis after acute myocardial infarction. Does adding antiplatelet agents, antithrombotics, or angioplasty make a difference?
    Figueredo VM; Amidon TM; Wolfe CL
    Postgrad Med; 1994 Dec; 96(8):45-51, 54. PubMed ID: 7991477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of combined thrombolytic and platelet inhibitor therapy on myocardial and microvascular perfusion.
    de Lemos J
    Md Med; 2001; Suppl():88-9. PubMed ID: 11434069
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intravenous thrombolytic therapy in myocardial infarction (review)].
    Staroverov II
    Ter Arkh; 2003; 75(10):80-3. PubMed ID: 14669614
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombolytic therapy: new dimensions 2009.
    Guha S; Mukherjee S; Hema MB
    Indian Heart J; 2009; 61(5):415-21. PubMed ID: 20635755
    [No Abstract]   [Full Text] [Related]  

  • 36. [The new frontier of antithrombotic therapy: ASA + warfarin, the ideal solution?].
    Cimminiello C; Soncini M; Casazza F
    G Ital Cardiol; 1995 Sep; 25(9):1187-93. PubMed ID: 8529856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patency, perfusion, performance--the desirable triplets of combination thrombolytic therapy.
    Wilcox R
    Eur Heart J; 2000 Sep; 21(18):1495-7. PubMed ID: 10973761
    [No Abstract]   [Full Text] [Related]  

  • 38. The ideal reperfusion strategy for the ST-segment elevation myocardial infarction patient with expected delay to percutaneous coronary intervention: paradise lost or paradise renamed?
    Henry TD; Larson DM
    JACC Cardiovasc Interv; 2009 Oct; 2(10):931-3. PubMed ID: 19850251
    [No Abstract]   [Full Text] [Related]  

  • 39. Advances in antithrombotic therapy: novel agents.
    Turpie AG; Weitz JI; Hirsh J
    Thromb Haemost; 1995 Jul; 74(1):565-71. PubMed ID: 8578525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.